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Semiquantitative immunohistochemical assessment of estrogen receptor (ER) is used to predict the likelihood of response to antiestrogen therapy in breast carcinoma. If semiquantitative immunohistochemical analysis leads to therapeutic decisions, the importance of standardization and quality control increases. ER assessment reproducibility was studied among 172 laboratories using tissue microarray slides with 20 tissue spots negative and 10 tissue spots expressing ER at low, medium, or high levels. More than 80% of the laboratories demonstrated ER positivity in the medium-and high-expressing tissue spots, but only about 43% succeeded with tissue spots with low expression. Poor interlaboratory agreement was based on insufficient retrieval efficacy as shown by additional tests using autoclave pretreatment. The immunohistochemical scores used to quantify therapeutic target molecules remain inconclusive as long as progress toward standardized immunohistochemical procedures and evaluation is not achieved. Tissue microarray technology has proved its suitability for large-scale immunohistochemical trials, giving rise to new dimensions in control assessment.
Immunohistochemical stains have become an indispensable part of laboratory procedures in pathology, both for diagnostic and research purposes. In the past, immunohistochemical analysis was used mostly for qualitative assessments, eg, lineage-specific markers such as antibodies against keratin were applied to determine the epithelial origin of a tumor.
Today, a growing number of markers are used that identify cell cycle-dependent proteins, receptors, oncogenes, and antioncogenes, even in fixed tissue. However, many of these require a semiquantitative evaluation to establish the degree of expression. Antiestrogen receptor antibodies were among the first markers introducing such a semiquantitative immunohistochemical assessment, followed by others such as progesterone receptor (PR) or HER2 (c-erbB2). Several methods are known (eg, immunoreactive score [IRS] , H score, quick score) for reporting estrogen receptor (ER) and PR results to clinicians. The IRS system is widely used in Germany. It is calculated by multiplication of the number of positively labeled cells (4 percentage groups) with the intensity of the staining reaction (3 grades). 1 However, to date, there is neither general agreement on the best way to assess the ER stains nor on which clinical parameters should be tested, ie, relapse-free survival or overall survival or response to tamoxifen therapy. 2 Evaluating the intensity of immunostains has been under debate, especially since different retrieval methods (with variable efficacy) and several detection systems are in use affecting this parameter. Nevertheless, the assessment of staining intensity in immunohistochemical analysis is increasingly required. The HercepTest (DAKO, Hamburg, Germany) has revitalized the estimation of staining intensity. The HercepTest score differentiates between grades 2+ and 3+ solely by the intensity of staining. 3 Emphasis must be placed on the fact that the results of both markers, ER and HER2, may have far-reaching consequences, ie, assessment of staining intensity may lead to major therapeutic decisions. 4, 5 Therefore, comparable results in semiquantitative immunohistochemical assessment demand a high degree of standardization and quality assessment to rule out bias owing to differences in tissue processing and in laboratory protocols for staining and evaluation by different observers. [6] [7] [8] As a first step toward standardization, we studied the possible influence of fixation and tissue processing on ER immunostains (study part A). Based on preliminary results in a previous study, we studied the influence on ER analysis of 22 different processing protocols, including delay of fixation, "cryosectioning," and adding important procedures such as decalcification before immunostaining. 9 Second, we report the results of a multicenter trial of immunohistochemical analysis in Germany, the study design shown in ❚Figure 1❚. For interlaboratory testing (study part B), a new tissue microarray (TMA) system was chosen, enabling each of the 172 participating laboratories to analyze 30 tissue spots from the same specimen on 1 slide ❚Image 1❚ and ❚Image 2❚. The slides had to be stained by the participating laboratories according to the method commonly applied in the corresponding laboratory. Moreover, interobserver agreement (study part C) was tested by comparing the self-assessment of each participating laboratory with that of a review of identical slides. By using TMA, it was possible for the first time to assess interobserver and interlaboratory variability in a large-scale study on the basis of multiple cases.
Materials and Methods
Study Part A: Influence of Tissue Processing and Fixation
Six cases of breast carcinoma were received immediately after surgical resection and divided into 22 portions. Each piece was processed using freshly prepared formalin (10%, ie, 3.7% formaldehyde, either neutral buffered or unbuffered with pH 5.5) or ethanol ❚Table 1❚. All tissues had a maximum diameter of 0.8 cm to permit optimal penetration of fixation fluids.
In addition, decalcification methods or simulation of intrasurgical cryosectioning were studied. Both procedures are used commonly for investigating metastasis to bone or for intrasurgical investigation of breast tumors.
TMA (Multiblock System)
All samples were embedded in standard paraffin blocks. On the respective H&E-stained sections, a representative tumor area was selected, the corresponding area was marked on the surface of the standard paraffin block, and tissue cores were punched from the designated area using a biopsy needle. All tissue cores (0.135 cm in diameter) were put into the TMA block covering up to 96 cores, using the commercially available multiblock system (Zytomed, Berlin, Germany; MaxArray, Zymed, San Francisco, CA). The final TMA contained 44 tissue cores differently processed in duplicate. ER-positive tissue cores were placed at positions 2, 3, 11, 20, 21, and 26 to 30 (breast carcinoma, stomach carcinoma, leiomyoma), and all other positions were filled with ER-negative tissue cores (lymphoma, seminoma, sarcoma, melanoma, chordoma, neuroendocrine tumors, ERnegative carcinoma; these tissues were used to test other markers; results are being reported elsewhere). 10, 11 The TMA block was routinely cut and the tissues mounted on self-coated slides (poly-L-lysine, Sigma, Deisenhofen, Germany). The procedure was identical to that used with any other standard paraffin block.
Immunohistochemical Analysis
Immunohistochemical analysis was performed twice on the same day using the same incubation fluids and substrate to exclude day-to-day variations. Before immunohistochemical analysis, microwave epitope retrieval was performed on the dewaxed slides (0.01-mol/L concentration of citrate buffer, pH 6.0; 22 minutes at 100°C). ERantibody clone 1D5 was applied using an optimized avidinbiotin-complex technique.
Evaluation
All immunostains were scored independently by 2 observers (R.v.W., M.M), and decisions on divergent scores were made using a multiheaded microscope. Scoring was done on a point scale, the IRS. 1 Staining intensity (weak, 1 point; moderate, 2 points; strong, 3 points) and percentage groups of positive tumor cells (<10%, 1 point; 11%-50%, 2 points; 51%-80%, 3 points; >80%, 4 points) were multiplied to achieve a score between 1 and 12. Three or more points were regarded as positive.
Study Part B: Interlaboratory Agreement
Quality assessment of interlaboratory and interobserver agreement in the immunohistochemical analysis was performed in a nationwide trial. The present report focuses especially on the results of ER assessment. Of the 200 laboratories asked to take part in this trial, 172 (86.0%) did so. Each participating laboratory received 1 unstained TMA slide for ER testing. This slide contained 30 different tissue spots from 15 cases, and each case was mounted twice. Images 1 and 2 show the TMA, slides at different magnifications and a stained tissue spot (spot 2 with high ER expression). TMAs were prepared as described in the preceding section from archival cases and fixed overnight in neutralbuffered formalin (routine procedures).
Interlaboratory agreement was tested by comparing the expected results, as known from repeated in-house staining procedures before the study, and the results obtained by the study assessors. The results are given in percentages of participants achieving the expected IRS. In addition, the proportion of positively labeled cells was compared, also disregarding the intensity of the reaction, distinguishing 3 groups: cases with less than 1%, 1% to 10%, or more than 10% positivity. Thus, the results could be compared with other studies using different scoring systems ❚Table 2❚.
Study Part C: Interobserver Agreement
All participating laboratories evaluated their ER stains using the widely accepted IRS system (see "Evaluation" in "Study Part A"). Although 3 or more points usually are regarded as ER-positive, this clinical threshold was disregarded in our statistical testing. All stained sections were returned for a panel assessment of the 5,160 tissue spots (172 × 30), which was done by two of us (R.v.W. and M.M.) on a multiheaded microscope. Figure 1 shows the study design. Statistical analysis of interobserver agreement is assessable by measuring the same stained tissues by 2 independent observers. For simple immunostains such as keratin, a tumor may be positive or negative (ie, binary results), and the agreement can be presented as a 2 × 2 table. For semiquantitative immunohistochemical assessment, however, the kappa statistic is the better measurement method. It also takes into account the agreement expected solely on the basis of chance and can be used if more than 2 categories are classified. Total agreement is indicated by a value of 1.0, but agreement by chance results in a zero value.
Although in the literature there is no generally accepted value of kappa that indicates sufficient (ie, good) agreement, Landis and Koch 12 suggested the following guidelines: kappa less than 0.4, poor to fair agreement; kappa 0.4 to 0.6, moderate agreement; kappa more than 0.6 to 0.8, substantial agreement; and kappa more than 0.8, almost perfect agreement. To measure the grade of agreement, a weighted kappa statistic was performed using the statistical software package SAS, version 8.0 (SAS, Cary, NC).
Enhanced Retrieval Pretreatment
Surplus slides were studied using a wet autoclave for heatinduced antigen retrieval pretreatment (0.01-mol/L concentration of citrate buffer, pH 6.0; 10 minutes at 124°C, slow cooling). All other steps of the protocol remained constant.
Results
Study Part A: Effects of Tissue Fixation
The highest IRS was achieved after immediate onset of fixation for 24 hours in neutral-buffered formalin (Table 1) .
This result was set as 100%, and the outcomes of all other immunostains were calculated as relative percentages. The results varied considerably among the 24 fixation and processing procedures. Whereas fixation periods for up to 72 hours in neutral-buffered formalin did not significantly alter the results (reactivity loss <5%), a major decrease occurred after simulation of cryosectioning before fixation or delayed onset of fixation, followed by ethanol fixation (-70%). In contrast, the pH of the formalin (buffered or unbuffered) showed little influence on the results of ER assessment.
Study Part B: Interlaboratory Agreement
To exclude interobserver variations from the evaluation of interlaboratory agreement, all tissue spots were reviewed by two of us (see "Materials and Methods"), and this review was compared with the expected results as achieved by repeated high-quality immunostains before the trial. Examples of how each tissue spot was evaluated are given in ❚Figure 2❚, showing a spot negative for ER (Figure 2A ), a high ER expresser ( Figure 2B ), an intermediate ER expresser (Figure 2C ), and a low ER expresser ( Figure 2D ). The results of the review process are given in the columns, and the selfassessment of the participating laboratories is shown in the rows.
By using the IRS, absolute agreement was achieved in 2 of the tissue spots by only 2.6% or 3.1% of the participants (Table 2 , spots 28 and 29). In contrast, the highest concordance was observed for tissue spot 2, showing 56.1% total agreement. Table 2 gives the detailed results for all tissue spots and shows the results using different stringency criteria.
To estimate the influence of staining intensity on reproducibility, the fractions of positively labeled nuclei were compared ( By using a 1% positivity threshold in tumors with high IRSs, 95.0% of the participating laboratories scored positive (best case, 99%). This number decreased in tumors with intermediate IRSs to 71.7% (best case, 79%) and in lowexpressing tumors to 55.7% (best case, 80%).
Study Part C: Interobserver Agreement
Overall, 5,160 tissue spots were reviewed for the study, of which 4,723 tissue spots (91.53%) were included as evaluable.
The majority of tissues excluded from further evaluation were unstained or overstained, or they showed no appropriate counterstaining, making an evaluation on a percentage basis impossible. Only 0.58% of the tissue spots were lost owing to an insufficient adhesion of tissues to the glass slides. More than 50% of adhesion losses occurred in only 1 spot (spot 3), a leiomyoma with a high collagen fiber content. Ten spots in the TMA were tissues with a known positivity for ER. The other 20 tissues were not included in the interobserver agreement evaluation, since obvious negativity (eg, spot 1, Figure 2A ) would have masked relevant findings. Of the self-recorded values, 4.3% were false-positive values in spot 1, although this case contained ER-negative tissue. On average, false positivity was self-recorded by participating laboratories in 2.8% (20 spots). The review yielded no true positivity in any of the negative tissue spots (0%). Therefore, the 2.8% may reflect the error rate of recording the self-assessment.
For only the fields positive for ER, 1,537 stained tissue spots were analyzed for interobserver and interlaboratory agreement. The detailed results for selected tissue spots are Figure 2 . Comparison of the results of the participating laboratories with the review assessment enabled the estimation of the interobserver agreement for each tissue spot separately, using the weighted kappa statistics ( Table 2) . The kappa values ranged between 0.410 and 0.724, and the mean value was 0.570. The use of more simplified scoring systems, ie, distinguishing only between positive (IRS of 3 or more) and negative IRS, did not result in a better kappa value. The same effect occurred if the staining intensity was excluded from the evaluation and if only the percentage groups of positive cells were assessed (weighted kappa, 0.480; detailed data not shown).
Autoclave Epitope Retrieval
By using autoclave pretreatment, no tissue losses were observed. The 20 tissue spots known to be negative for ER remained totally negative (no false positivity). All 10 tissue spots known to be positive showed moderate to strong signals for ER in more than 80% of tumor cells, corresponding to an IRS value of 8 to 12. This result occurred regardless of the original grading into low, intermediate, or high ER expressers.
Discussion
Quality assessment in immunohistochemical analysis comprises organizational structures and responsibilities for procedures, processes, and facilities, as well as for quality assurance. The last can be subdivided into technical and interpretative aspects, both of which remain a constant challenge in immunohistochemical analysis, especially if used semiquantitatively (for review see Barnes et al, 2 O'Leary, 5 Ruiter et al, 13 and literature therein). Nevertheless, a growing number of prognostic markers and the need to determine the amount of several receptors, oncoproteins, or tumor suppressor proteins has resulted in a number of approaches to semiquantitative immunohistochemical assessment, although frequently using a homemade definition.
We report on the largest study to date evaluating interlaboratory and interobserver agreement on semiquantitative immunohistochemical ER assessment; results are based on the evaluation of more than 1,500 tissue spots stained by 172 participating laboratories. All organizational and laboratory efforts to obtain meaningful data were reduced considerably by using TMA system multiblock (TMA-SM), permitting the testing of multiple tissues on 1 slide.
TMAs also were used to evaluate the influence of fixation and tissue processing. Best results were achieved after immediate start of fixation combined with a fixation period between 24 and 72 hours. Even longer intervals, such as a weekend fixation or the use of unbuffered formaldehyde, did not result in decreased values. In contrast, results were impaired by pitfalls that might easily occur in daily practice: freezing of tissue for cryosectioning, followed by fixation lasting only a few hours to place the sample into the automatic tissue processor on the same day. As suggested by our data, the result for ER may decline by up to 50% (Table 1) . Consequently, tissue fixation and processing should no longer be considered as a "black box," but fixation should be monitored and recorded for reasons of standardization. A reasonable approach for standardization should include the documentation of the time of surgical resection and the start and length of fixation using neutral-buffered formalin as fixative. The period of fixation should be between 16 and 72 hours (at least overnight) on small tissue samples of no more than 1 cm in diameter. Sufficient retrieval methods based on heating have overcome the former problems of overfixation, and, nowadays, underfixation seems to be a more serious problem. To simplify standardization in routine practice without prolonging the diagnostic turnaround time, we are preparing special "receptor blocks" in our institute. From each putative breast neoplasm of a sufficient size, 1 small piece is immediately selected after submission to the pathology department, fixed separately for 16 to 24 hours, and subsequently used for all immunohistochemical analyses.
Regarding interlaboratory reproducibility, 4 tissue spots expressing ER at high levels yielded the highest interlaboratory concordance (Table 2 ). This result was independent of scoring systems or thresholds. Similar results were recently reported in a large-scale study in England 6, 8 ; the most appropriate explanation is that participating laboratories even with suboptimal sensitivity were able to detect the samples expressing high levels of ER. The staining intensity is highly responsible for the lack of agreement, because an isolated view on the percentage concordance of positive cells led to an improvement up to at least 82% ( Table 2 ). The same effect occurred with the rate of false negativity.
Which of the thresholds reliably indicates ER sensitivity of a given breast tumor is under debate and obviously needs further study. Jensen and DeSombre 14 stated that there should be different thresholds for premenopausal and postmenopausal cases. However, the question of the right cutoff for semiquantitative immunohistochemical assessment lies beyond the aims of the present study, and we therefore have given the data in several columns to enable comparison with other studies. We focused on interlaboratory agreement and the technical possibilities to achieve more standardized ER analyses. Only if standardization and high quality control that enables the comparability of different study results have been achieved does it seem to make sense to perform large meta-analyses of clinical trials that can set reliable (ie, clinically meaningful) cutoff values.
Interlaboratory disagreement became more obvious among the intermediate cases and was worst among the lowexpressing tumors. The number of laboratories failing to detect any ER positivity in the latter group (spots 11, 21, 26, and 28) varied between 20.3% and 55.2% (mean, 44.3%). The relatively wide range within the latter group demonstrates the necessity to test more than just 1 case of each category (low, intermediate, and high expressers). Therefore, the TMA system seems to offer more reliable results compared with studies using only 1 case for each category.
Whereas a close agreement of 60.5% to 88.4% (or 82%-97% for percentage groups only) seems to be fairly good for the tissue spots with strong positivity, the results of the spots with lower scorings are rather disappointing and closely resemble the results of the United Kingdom National External Quality Assessment Service report for immunocytochemistry. 6 What are the most likely reasons for such a low interlaboratory agreement? Three possible factors were excluded in our study: (1) different fixation procedures, by using identical cases for all participating laboratories; (2) interobserver variability, by calculating interlaboratory agreement only with the data from the review process; and (3) testing on single cases only, by using the TMA-SM including several low, intermediate, and high ER expressers. Another possible factor that might have influenced the results is the use of different antibody clones by the participating laboratories. This assumption is not likely owing to our own and other reported results. As long as standard fixation procedures (1-4 days, neutral-buffered formalin) were maintained, no significant differences were observed between frequently used antibody clones or different detection systems. 9 , 15 Rhodes et al 7 also demonstrated that variations in fixation and tissue preparations were not the limiting factors preventing different laboratories from achieving optimal ER demonstration. They concluded that the efficiency of the heat-mediated antigen retrieval was the most likely factor preventing some participants from achieving optimal demonstration of hormonal receptors. 7 This finding supports the results of autoclave pretreatment in our study. Strong positivity of all positive tissue spots (but no false positivity in the 20 ER-negative spots of the TMA) indicates that epitope retrieval is the major influencing factor for achieving a high sensitivity in semiquantitative immunohistochemical ER assessment. Moreover, in a multicenter study involving 15 French laboratories, the appropriate duration of heating for antigen retrieval was the crucial factor for suboptimal results, a finding in accordance with previous reports that only after at least 20 minutes of heating is the optimal effect of antigen retrieval reached. 16, 17 Therefore, after ruling out the most serious pitfalls of fixation and tissue processing, all efforts should be focused on improved standardization of retrieval methods. In this respect also, the TMA system seems to be a useful tool to perform such studies with limited effort since it permits the simultaneous study of multiple, differently fixed cases or cell lines with low, medium, and high content of ER, PR, or HER2.
The interobserver agreement using the IRS was moderate to good in all cases. Interestingly, no trend toward better interobserver agreement in the high-expressing cases was observed. Estimating the staining intensity on a subjective basis did not lead to reduced weighted kappa values, indicating that the interobserver agreement cannot be increased by using scoring systems without evaluation of the intensity of the immunostains. To put it very clearly: the scoring systems are not the source of error, but rather the retrieval methods used in the different laboratories.
By using the new TMA-SM, it was possible for a large number of participating laboratories to test many cases with each laboratory receiving almost identical tissue spots. Although every participating laboratory had to stain only 1 slide, statistically meaningful numbers could be assessed owing to the use of TMA. Tissue adhesion of the small tissue spots was excellent in our system. Only a few participating observers had difficulties with the checkerboard-like assessment of their results, but an explanatory manual should reduce this rate in future trials. It then will be possible to include several cell lines or tissues with known amounts of receptor protein for national or international trials, thereby enabling semiquantitative immunohistochemical trials at low cost.
With regard to therapeutic implications, our study reveals that the reproducibility of immunohistochemical ER stains is not satisfactory. Tools are needed to enable intralaboratory and interlaboratory standardization. TMA slides could provide an appropriate and inexpensive instrument for this purpose. In our laboratory, we have generated a mini-TMA (containing 4-9 tissue spots or cell line spots with high and low ER and PR expression and HER2 overexpression) from which sections are added on every slide prepared for steroid receptor or HER2 assessment. This enables the quality of immunostains (on-slide control array) to be monitored with no need for additional reagents or antibodies, thus fulfilling the requirements O'Leary 5 has formulated in a review about standardization in immunohistochemical analysis. Our on-slide control system has proved its usefulness in our laboratory for more than a year now; it is compatible with automated immunostainers based on capillary action systems, and the controls are stored on the slides for documentation even after many years.
